Recital 6, Decision_act (EU) 2024/2767

In forcesince 30 Oct 2024

In addition, in accordance with point 4(b) of Annex VII to Regulation (EU) 2024/573, a reference value should be calculated for each producer and importer that has reported on the placing on the Union market of hydrofluorocarbons for being used for the production of metered dose inhalers for the delivery of pharmaceutical ingredients. That reference value should be calculated on the basis of the annual average of the quantities of hydrofluorocarbons lawfully placed on the Union market for such usage, from 1 January 2020 as reported under Article 19 of Regulation (EU) No 517/2014 and under Article 26 of Regulation (EU) 2024/573, for the years available, on the basis of available data. Accordingly, for calculating the reference values referred to in point 4(b) of Annex VII to Regulation (EU) 2024/573 for the period from 1 January 2025 to 31 December 2026, any data reported by producers and importers in accordance with Article 19 of Regulation (EU) No 517/2014 for 2020, 2021, 2022 and 2023 should be taken into account.